0.05Open0.05Pre Close0 Volume1.04K Open Interest16.00Strike Price0.00Turnover91.33%IV26.68%PremiumNov 15, 2024Expiry Date0.00Intrinsic Value100Multiplier9DDays to Expiry0.05Extrinsic Value100Contract SizeAmericanOptions Type0.0652Delta0.0685Gamma253.40Leverage Ratio-0.0121Theta0.0002Rho16.52Eff Leverage0.0026Vega
Elanco Animal Health Stock Discussion
3 mins ago
Elanco Receives FDA Approval for Credelio Quattro™ (Lotilaner, Moxidectin, Praziquantel, and Pyrantel Chewable Tablets), the Broadest(I) Canine Oral Parasiticide Protection in a Single Monthly Dose
No comment yet